Skip to main content

Immunovant, Inc 10-Q for FY2026 Q1

Immunovant, Inc. (IMVT)

10-Q 2025-08-11 For: 2025-06-30
View Original
Added on April 11, 2026

About this 10-Q

Immunovant, Inc filed this 10-Q on August 11, 2025, covering the quarter ended June 30, 2025 (FY2026 Q1).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$120.61M
compared with a net loss of $87.15M a year earlier
Diluted EPS
-$0.71
compared with -$0.60 a year earlier